HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Abstract Full Text (PDF) All Versions of this Article: 288/6/H2708    most recent 01017.2003v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (14) Citing Articles via Google Scholar Google Scholar Articles by Paetsch, I. Articles by Nagel, E. Search for Related Content PubMed PubMed Citation Articles by Paetsch, I. Articles by Nagel, E.

Magnetic resonance stress tagging in ischemic heart disease

¹Department of Cardiology, German Heart Institute, Berlin; ²Department of Cardiology and Angiology, University of Freiburg, Freiburg, Germany; ³Institute for Biomedical Engineering, University and ETH, Zurich, Switzerland; and ⁴Department of Radiology, Johns Hopkins University, Baltimore, Maryland

Submitted 28 October 2003 ; accepted in final form 4 January 2005

	ABSTRACT

TOP ABSTRACT METHODS RESULTS DISCUSSION GRANTS REFERENCES

 
High-dose dobutamine magnetic resonance stress testing has been shown to be superior to dobutamine stress echocardiography for diagnosis of coronary artery disease (CAD). We determined the feasibility of quantitative myocardial tagging during low- and high-dose dobutamine stress and tested the ability of global systolic and diastolic quantitative parameters to identify patients with significant CAD. Twenty-five patients suspected of having significant CAD were examined with a standard high-dose dobutamine/atropine stress magnetic resonance protocol (1.5-T scanner, Philips). All patients underwent invasive coronary angiography as the standard of reference for the presence (n = 13) or absence (n = 12) of significant CAD. During low-dose dobutamine stress, systolic (circumferential shortening, systolic rotation, and systolic rotation velocity) and diastolic (velocity of circumferential lengthening and diastolic rotation velocity) parameters changed significantly in patients without CAD (all P < 0.05 vs. rest) but not in patients with CAD. Identification of patients without and with CAD during low-dose stress was possible using the diastolic parameter of "time to peak untwist." At high-dose stress, none of the global systolic or diastolic parameters showed the potential to identify the presence of significant CAD. With myocardial tagging, a quantitative analysis of systolic and diastolic function was feasible during low- and high-dose dobutamine stress. In our study, the diastolic parameter of time to peak untwist as assessed during low-dose dobutamine stress was the most promising global parameter for identification of patients with significant CAD. Thus quantitative myocardial tagging may become a tool that reduces the need for high-dose dobutamine stress.

dobutamine; echocardiography; systolic rotation velocity; time to peak untwist; diastolic rotation velocity

Myocardial tagging may be advantageous: with this technique, the myocardium is labeled with grid or line tags at end diastole, e.g., by spatial periodic modulation of magnetization (SPAMM) (1, 33). The SPAMM technique was improved by achieving a tag contrast throughout the cardiac cycle (C-SPAMM) (6) and by compensating for through-plane motion of the heart (i.e., slice following) (7): the tag lines are "fixed" on the tissue and deform with the myocardium throughout the cardiac cycle. Consequently, quantification of grid deformation allows an exact and objective assessment of global and regional wall motion (21, 33): different components of myocardial motion, such as circumferential shortening, rotation, or strain along the myocardial fiber direction, can be determined. The use of myocardial tagging has provided new insights into the (patho)physiology of regional wall motion (3, 27), and several parameters have been described as being useful to identify an ischemic response of the myocardium (2, 26).

Rotation might be a sensitive marker for myocardial ischemia and may be advantageous, because it represents a measure of myocardial contractility that is, only to a minor degree, influenced by changes of pre- and afterload (13). Dong et al. (5) found that diastolic relaxation and untwisting correlate closely. Circumferential shortening has been shown to be the major component of myocardial strain at rest and during dobutamine treatment (8) and has been successfully used to detect viable myocardium during low- and medium-dose dobutamine stimulation (9, 17). Recently, Kuijpers et al. (18) reported that even the visual inspection of tagged images acquired during high-dose dobutamine stress was more sensitive for the detection of significant CAD than the visual inspection of conventional cine scans.

Thus the objective of the present study was to assess whether 1) myocardial tagging with slice following is feasible during a high-dose dobutamine stress protocol and 2) whether global quantitative parameters that may have the potential to distinguish patients with and without significant CAD during low-dose dobutamine stimulation can be identified.

	METHODS

TOP ABSTRACT METHODS RESULTS DISCUSSION GRANTS REFERENCES

 
Study Population

Thirty-one consecutive patients (23 men and 8 women, age 59.0 ± 7.3 yr) with suspected CAD or suspected restenosis after prior percutaneous coronary intervention were examined with a standard dobutamine/atropine stress protocol before clinically indicated invasive coronary angiography. All patients had normal regional and global systolic left ventricular function at rest, as assessed by visual inspection and volumetry [area length ejection fraction = 60.6% (SD 3.6)]. Patients with a history or ECG signs of prior myocardial infarction, valvular disease, complete bundle branch block, or general contraindications to dobutamine or MRI were excluded. Twenty-two patients had arterial hypertension, 6 had diabetes mellitus, 15 had dyslipoproteinemia, 11 were active smokers, and 10 had a positive family history of CAD.

Written informed consent was obtained from all patients, and the research protocol was approved by the Committee on Clinical Investigation of our hospital.

The patient characteristics are summarized in Table 1.

The examinations were performed with a 1.5-T whole body MR scanner (ACS NT, Philips Medical Systems, Best, The Netherlands) with the patient in the supine position. A five-element phased-array cardiac surface coil was used for signal acquisition. Images were acquired during end-expiratory breath holds; the ECG was continuously monitored, and blood pressure was measured at 1-min intervals.

After acquisition of two rapid localizer scans to identify the intrinsic axes of the heart, three conventional short-axis cine scans were performed at the basal, midventricular, and apical level (balanced gradient echo sequence as follows: echo time, repetition time, and flip = 1.9, 4, and 60, respectively); the scans were repeated at all stress levels and evaluated visually on the scanner console to check for inducible wall motion abnormalities. At rest and at each dobutamine stress level, a slice-following C-SPAMM-based tagging pulse sequence was performed at the apical short-axis level (segmented k-space, multishot FFE-EPI sequence as follows: repetition time, echo time, and flip = 25, 7.4, and 25, respectively) (30). The tagging sequences consisted of two sets of images with horizontally and vertically modulated stripes acquired within one breath hold. The heart phase interval was <40 ms in all data sets, and 15–25 heart phases were recorded depending on heart rate. Tagged images were acquired at rest, during treatment with dobutamine at 10 µg·kg^–1· min^–1, and during maximum dobutamine stress.

Stress Protocol

Dobutamine was infused at 10, 20, 30, and 40 µg·kg^–1·min^–1 at 3- to 5-min intervals. If target heart rate [defined as 85% of age-predicted heart rate (220 – age)] was not achieved at the maximum dobutamine level, additional atropine was applied (in 0.25-mg increments to a maximum of 1.5 mg). The stress protocol was terminated if target heart rate was reached or if the patient experienced progressive angina/dyspnea or significant side effects related to the dobutamine infusion or, in the case of visual detection, a new or worsening regional wall motion abnormality in at least one myocardial segment.

Image Analysis

After multiplication of the two images to obtain the grid, analysis of the apical short-axis slices was performed with semiautomatic software [MACAVA, ETH; the principles of this software application have been described in detail elsewhere (28)], which allows tracing of the intersection points of the tag lines in each phase image (Fig. 1). Epi- and endocardial borders of the left ventricle were defined manually in the first-phase image. By means of the tagging grid, the software determined the epi- and endocardial borders in all subsequent heart phases. As the basis for further analysis, 72 midmyocardial points were calculated: for definition of these points, a polar coordinate system was introduced, and points were distributed circumferentially every 5°; all quantitative parameters as given in Tables 2 and 3 represent the mean values of all segments of the apical slice. The end-diastolic and end-systolic phase images were defined as the first image acquired after the R-wave trigger and the phase image with the smallest left ventricular cavity area, respectively (28).

View larger version (117K): [in this window] [in a new window]   Fig. 1. Representative end-diastolic and end-systolic apical images of a patient without significant coronary artery disease (CAD). A: rest. B: low-dose dobutamine stress. C: high-dose dobutamine stress. Note increase in systolic rotation and endocardial motion from rest to low-dose stress.

Parameters were normalized to values at rest. In addition, durations and velocities were normalized to percentage of the duration of systole to account for interindividual differences and stress-related changes in heart rate.

Circumferential shortening (CS) represents the relative shortening of the distance between two adjacent circumferential points, expressed as a percentage of the end-diastolic distance; mean CS was calculated using all 72 midmyocardial points. Diastolic lengthening is expressed as negative values of CS.

Maximal lengthening velocity is the first derivative of the CS curve, expressed as percent per second.

Rotation is the apical rotation of each midmyocardial point around the center of gravity of the left ventricle, expressed in degrees. For further analysis, mean rotation of all 72 midmyocardial points was considered. As viewed from the apex, counterclockwise rotation was defined as a positive angle and clockwise rotation as a negative angle.

Rotation velocity represents the rotational angle of a midmyocardial point between two heart phases divided by the interphase interval (1st derivation of the rotation curve; degrees/%systole). For the analysis, all midmyocardial points were used.

Time to peak untwist is the time between end systole and peak diastolic rotation velocity, expressed as percentage of systole.

Statistics

Stress levels were compared with Student's t-test for paired comparisons. Comparisons between patients with and without CAD were done with Wilcoxon's test. Values are means (SD). Statistical significance was assumed for P < 0.05.

Sensitivity, specificity, accuracy, and predictive values (positive and negative) were calculated according to standard definitions. For "time to peak untwist," a receiver operating curve analysis was carried out to determine its ability to differentiate between patients with and patients without CAD, and the area under the curve was calculated.

	RESULTS

TOP ABSTRACT METHODS RESULTS DISCUSSION GRANTS REFERENCES

 
Dobutamine stress testing was performed in 31 patients; 6 patients were excluded from the analysis because of poorimage quality. The remaining 25 patients formed the study population. Target heart rate was reached in 21 of 25 patients; reasons for premature termination of the stress test included severe angina, hypertensive dysregulation, severe headache/nausea, and atrial fibrillation (4 patients). Dobutamine and atropine doses were 34.1 µg·kg^–1·min^–1 (SD 8.9) and 0.5 mg (SD 0.5), respectively, with administration of atropine in 18 patients.

The quantitative analysis of stress MR tagging refers to 25 apical short-axis views at rest and under low-dose dobutamine (10 µg·kg^–1·min^–1) and to 21 apical short-axis views under maximum stress (4 patients failed to reach target heart rate). Angiographically, 13 of 25 patients had significant CAD (i.e., 1 epicardial vessel with >2 mm diameter had >50% luminal diameter reduction as assessed by quantitative coronary angiography).

Systolic Cardiac Function

CS. In patients without CAD, CS increased at low-dose stress (P < 0.05) but returned to baseline values at maximum stress. In patients with CAD, neither low- nor high-dose stress significantly influenced peak CS, nor did time of peak CS (Table 3) change under low- or high-dose stress. Systolic rotation velocity was significantly reduced in patients with CAD.

Rotation. In accordance with previous studies, all patients showed a counterclockwise rotation of the apex in systole [13.5 degrees (SD 3.2) and 12.1 degrees (SD 3.6) in patients with and without CAD, respectively, P = not significant] and a clockwise rotation in diastole at rest.

In patients without CAD, peak rotation and maximal systolic rotation velocity increased with increasing dobutamine stress (Table 2 and 3).

In contrast, patients with CAD showed neither an increase in peak rotation nor an increase in systolic rotation velocity during low-dose stress, although a significant increase was found during high-dose dobutamine stress. However, for low- and high-dose stress, the parameters did not significantly differ between the patient groups (without vs. with CAD).

Diastolic Cardiac Function

Diastolic lengthening. In patients without CAD, velocity of diastolic fiber lengthening first significantly increased at low-dose stress (P < 0.02 vs. rest) but then significantly decreased at maximum stress (P < 0.01 vs. low-dose stress).

In patients with CAD, no significant changes were found during stress. No significant difference was found between patients without and with CAD.

Time to peak untwist. Time to peak untwist significantly decreased at low-dose stress in patients without CAD but did not further change with high-dose stress. In contrast, in patients with CAD, time to peak untwist significantly increased from rest to low-dose stress (P < 0.05). Time to peak untwist was significantly different between patients with and without CAD (P < 0.01).

Diastolic rotation velocity. In patients without CAD, maximal diastolic rotation velocity increased with increasing stress; however, patients with CAD showed a significant increase at high-dose stress only (Fig. 2).

View larger version (17K): [in this window] [in a new window]   Fig. 2. Representative rotation-time plots of an apical slice from a patient without CAD (A) and a patient with CAD (B). Rotation at low- and high-dose dobutamine stress is expressed as percent change from rest. Solid vertical line indicates end systole (ES). For the patient without CAD, there was no change in time to peak untwist between low- and high-dose stress (solid and dotted arrows, respectively). For the patient with CAD, time to peak untwist was similar at low- and high-dose stress but was delayed compared with that for the patient without CAD.

Because time to peak untwist showed the largest effect for the comparison of patients with CAD vs. patients without CAD, this parameter was tested for its potential ability to detect patients with significant CAD. Thus a receiver operating curve analysis was carried out (Fig. 3); the results of using a cutoff value of 90% are shown in Table 4 and Fig. 4.

View larger version (9K): [in this window] [in a new window]   Fig. 3. Receiver operating curve analysis to determine the cutoff value for time to peak untwist to diagnose significant CAD. AUC, area under the curve.

View larger version (8K): [in this window] [in a new window]   Fig. 4. Detection of patients with and without significant CAD (CAD+ and CAD–) using time to peak untwist during low-dose dobutamine stress. Time to peak untwist (90% cutoff, dashed line) correctly identified 8 of 12 patients without CAD and 11 of 13 patients with CAD.

	DISCUSSION

TOP ABSTRACT METHODS RESULTS DISCUSSION GRANTS REFERENCES

The findings of our study are in agreement with the well-known concept of the ischemic cascade, which states that diastolic impairment is an early ischemic alteration. With stress tagging, we found significant differences between patients with and those without CAD mainly reflected in diastolic parameters (time to peak untwist and diastolic rotation velocity) but also in a single systolic parameter (systolic rotation velocity). It is noteworthy that the main effects occurred during low-dose stress, especially with regard to time to peak untwist. Thus quantitative stress MR tagging appears to be advantageous, because it might not be necessary to proceed to higher dobutamine levels to detect the presence of significant CAD.

Cardiac rotation resulting in a systolic wringing motion of the left ventricle is an energy-efficient means to achieve high intracavitary pressure with minimal fiber shortening. First, studies in animals and invasive studies in transplanted hearts demonstrated a pronounced rotation during dobutamine stress (2, 20, 26). In addition, a reduction of apical rotation was observed during myocardial ischemia. Gibbons Kroeker et al. (10) demonstrated a decreased apical rotation after left anterior descending coronary artery or left circumflex artery occlusion in dogs. Knudtson et al. (15) showed that apical rotation is a sensitive indicator of ischemia as assessed during percutaneous revascularization of the left anterior descending coronary artery in patients. Our results are in accordance with these previously published reports and indicate that, during low-dose dobutamine stress, systolic apical rotation is significantly reduced in patients with significant CAD. However, under high-dose dobutamine stress, the large interindividual variability between patients precluded the use of systolic rotation to differentiate between patients with and without CAD.

Diastolic dysfunction has been assessed in a variety of myocardial pathologies using invasive and noninvasive procedures: with myocardial tagging, it was possible to characterize diastolic dysfunction in patients with myocardial hypertrophy or infarction (23, 29). In particular, it was demonstrated that an impairment of the early filling period marked the onset of ischemia; in addition, the reduced velocity of peak diastolic pressure decay and postejection thickening of ischemic segments in early diastole were reported to be indicative of early ischemic reactions (19, 32).

Consequently, the value of diastolic parameters as measured with stress MR tagging for the detection of significant CAD has been examined. In an animal model, Rademakers et al. (26) demonstrated that maximal diastolic untwisting was accelerated during dobutamine infusion and further increased with its dose; these findings led to the hypothesis of an "energy storage" during systole that is subsequently released during diastole. The investigators reported that diastolic untwisting occurred before ventricular filling; this dissociation had been attributed to the dobutamine stimulation, and the authors could identify the energy-dependent early diastolic relaxation as a factor that is crucial for adequate ventricular filling. Our data support the idea that diastolic untwisting represents a promising parameter for the detection of patients with significant CAD.

Limitations

The time-consuming analysis of the tagged images renders stress MR tagging unsuitable for larger patient populations or in clinical routine. Recent software developments, such as HARP (24) and FastHARP (16), may provide a means to overcome this drawback.

Large interindividual differences of wall motion parameters have been reported at rest (25) and are further pronounced during dobutamine infusion (4); thus we decided to calculate and report the percent changes relative to the baseline values to account for the observed high interindividual variability.

In addition, the high number of patients with arterial hypertension (22 of 25) might have influenced our results, because in these patients the combined effects of dobutamine on (sub)clinical diastolic dysfunction and the presence of significant CAD were assessed. However, our aim was to study the feasibility of high- and low-dose dobutamine stress tagging and to identify those parameters that might be useful in future software applications to be displayed, e.g., on the console of the scanner.

It seems reasonable to compare the results of stress MR tagging with other functional methods for ischemia detection in future studies (rather than with invasive coronary angiography alone). We thought it useful, however, to first compare stress MR tagging with the clinical standard of reference to obtain a preliminary and raw estimate of its applicability as a gatekeeper for invasive testing.

Another limitation of our study is the restricted temporal resolution of the tagging technique applied especially compared with, e.g., the optical device technique used in previous invasive animal studies (11). This technique allowed online measurements of cardiac motion. The restricted temporal resolution of MR tagging limits the evaluation of parameters of myocardial motion, which change rapidly over time. However, MR tagging is advantageous with regard to its noninvasiveness; thus our aim was to test in patients its ability to aid in the detection of significant CAD. In addition, with further technical refinements of the tagging sequences, a more detailed analysis of myocardial motion can be expected.

Load dependence has been shown to play an important role: the effects of load, contractility, and heart rate manipulations on left ventricular twist are manifested by changes in the amplitude and dynamics of torsion (12). In our patient study, we did not perform invasive assessment of the hemodynamic changes under dobutamine stress for ethical reasons; thus we cannot exclude a potential influence of the stress-induced hemodynamic changes on the parameters measured. However, heart rate and blood pressure did not significantly differ between patients with and without CAD, thereby minimizing the parameters' potential influence.

Conclusion

MRI myocardial tagging at low-dose dobutamine stress is feasible and showed significant differences between patients with and without significant CAD. High-dose dobutamine stress MR tagging is feasible as well but, with the available MR techniques, was not superior to low-dose dobutamine stress for the detection of CAD. Thus quantitative myocardial tagging may become a tool that reduces the need for high-dose dobutamine stress.

	GRANTS

TOP ABSTRACT METHODS RESULTS DISCUSSION GRANTS REFERENCES

 
This research project was supported by the German Cardiac Society. D. Föll was supported by the German Cardiac Society. A. Wahl was supported by Swiss National Funds.

	ACKNOWLEDGMENTS

 
We thank Gudrun Grosser, Heike Mueller, and Janina Rebakowski for assistance in performing the dobutamine stress MR examinations.

	FOOTNOTES

 

Address for reprint requests and other correspondence: E. Nagel, German Heart Institute Berlin, Augustenburger Platz 1, 13353 Berlin, Germany (E-mail: eike.nagel{at}dhzb.de)

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

^* I. Paetsch and D. Föll contributed equally to this work.

	REFERENCES

TOP ABSTRACT METHODS RESULTS DISCUSSION GRANTS REFERENCES

 

1. Axel LDL. MR imaging of motion with spatial modulation of magnetization. Radiology 171: 841–845, 1989.[Abstract/Free Full Text]
2. Buchalter MB, Rademakers FE, Weiss JL, Rogers WJ, Weisfeldt ML, and Shapiro EP. Rotational deformation of the canine left ventricle measured by magnetic resonance tagging: effects of catecholamines, ischaemia, and pacing. Cardiovasc Res 28: 629–635, 1994.[Abstract/Free Full Text]
3. Buchalter MB, Weiss JL, Rogers WJ, Zerhouni EA, Weisfeldt ML, Beyar R, and Shapiro EP. Noninvasive quantification of left ventricular rotational deformation in normal humans using magnetic resonance imaging myocardial tagging. Circulation 81: 1236–1244, 1990.[Abstract/Free Full Text]
4. Carstensen S, Ali S, Stensgaard-Hansen F, Toft J, Haunso S, Kelbaek H, and Saunamaki K. Dobutamine-atropine stress echocardiography in asymtomatic healthy individuals–the relativity of stress-induced hyperkinesia. Circulation 92: 3453–3463, 1995.[Abstract/Free Full Text]
5. Dong SJ, Hees PS, Siu CO, Weiss JL, and Shapiro EP. MRI assessment of LV relaxation by untwisting rate: a new isovolumic phase measure of tau. Am J Physiol Heart Circ Physiol 281: H2002–H2009, 2001.[Abstract/Free Full Text]
6. Fischer SE, McKinnon GC, Maier SE, and Boesiger P. Improved myocardial tagging contrast. Magn Reson Med 30: 191–200, 1993.[Web of Science][Medline]
7. Fischer SE, McKinnon GC, Scheidegger MB, Prins W, Meier D, and Boesiger P. True myocardial motion tracking. Magn Reson Med 31: 401–413, 1994.[Web of Science][Medline]
8. Garot J, Bluemke DA, Osman NF, Rochitte CE, Mc Veigh ER, Zerhouni EA, Prince JL, and Lima JAC. Fast determination of regional myocardial strain fields from tagged cardiac images using harmonic phase MRI. Circulation 101: 981–988, 2000.[Abstract/Free Full Text]
9. Geskin G, Kramer CM, Rogers WJ, Theobald TM, Pakstis D, Hu YL, and Reichek N. Quantitative assessment of myocardial viability after infarction by dobutamine magnetic resonance tagging. Circulation 98: 217–223, 1998.[Abstract/Free Full Text]
10. Gibbons Kroeker C, Tyberg J, and Beyar R. Effects of ischemia on left ventricular apex rotation. Circulation 92: 3539–2548, 1995.[Abstract/Free Full Text]
11. Gibbons Kroeker CA, Ter Keurs HE, Knudtson ML, Tyberg JV, and Beyar R. An optical device to measure the dynamics of apex rotation of the left ventricle. Am J Physiol Heart Circ Physiol 265: H1444–H1449, 1993.[Abstract/Free Full Text]
12. Gibbons Kroeker CA, Tyberg JV, and Beyar R. Effects of load manipulations, heart rate, and contractility on left ventricular apical rotation. An experimental study in anesthetized dogs. Circulation 92: 130–141, 1995.[Abstract/Free Full Text]
13. Hansen DE, Daughters GT, Alderman EL, Ingels NB, Stinson EB, and Miller DC. Effect of volume loading, pressure loading, and inotropic stimulation on left ventricular torsion in humans. Circulation 83: 1315–1326, 1991.[Abstract/Free Full Text]
14. Hundley WG, Hamilton CA, Thomas MS, Herrington DM, Salido TB, Kitzman DW, Little WC, and Link KM. Utility of fast cine MR imaging and display for the detection of myocardial ischemia in patients not well suited for second harmonic stress echocardiography. Circulation 100: 1697–1702, 1999.[Abstract/Free Full Text]
15. Knudtson ML, Galbraith D, Hildebrand KL, Tyberg JV, and Beyar R. Dynamics of left ventricular apex rotation during angioplasty. Circulation 96: 801–808, 1997.[Abstract/Free Full Text]
16. Kraitchman DL, Sampath S, Castillo E, Derbyshire JA, Boston RC, Bluemke DA, Gerber BL, Prince JL, and Osman NF. Quantitative ischemia detection during cardiac magnetic resonance stress testing by use of fastHARP. Circulation 107: 2025–2030, 2003.[Abstract/Free Full Text]
17. Kramer CM, Rogers WJ Jr, Mankad S, Theobald TM, Pakstis DL, and Hu YL. Contractile reserve and contrast uptake pattern by magnetic resonance imaging and functional recovery after reperfused myocardial infarction. J Am Coll Cardiol 36: 1835–1840, 2000.[Abstract/Free Full Text]
18. Kuijpers D, Ho KY, van Dijkman PR, Vliegenthart R, and Oudkerk M. Dobutamine cardiovascular magnetic resonance for the detection of myocardial ischemia with the use of myocardial tagging. Circulation 107: 1592–1597, 2003.[Abstract/Free Full Text]
19. Kumada T, Karliner JS, Pouleur H, Gallagher KP, Shirato K, and Ross J. Effects of coronary occlusion on early diastolic events in dogs. Am J Physiol Heart Circ Physiol 237: H542–H549, 1979.[Free Full Text]
20. Moon MR, Ingels NB, Daughters GT, Stinson EB, Hansen DE, and Miller DC. Alterations in left ventricular twist mechanics with inotropic stimulation and volume loading in human subjects. Circulation 89: 142–150, 1994.[Abstract/Free Full Text]
21. Moore CC, Lugo-Olivieri CH, McVeigh ER, and Zerhouni EA. Three-dimensional systolic strain patterns in the normal human left ventricle: characterization with tagged MR imaging. Radiology 214: 453–466, 2000.[Abstract/Free Full Text]
22. Nagel E, Lehmkuhl HB, Bocksch W, Klein C, Vogel U, Frantz E, Ellmer A, Dreyse S, and Fleck E. Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress echocardiography. Circulation 99: 763–770, 1999.[Abstract/Free Full Text]
23. Nagel E, Stuber M, Lakatos M, Scheidegger MB, Boesiger P, and Hess OM. Cardiac rotation and relaxation after anterolateral myocardial infarction. Coron Artery Dis 11: 261–267, 2000.[CrossRef][Web of Science][Medline]
24. Osman NF, Kerwin WS, Mc Veigh ER, and Prince JC. Cardiac motion tracking using line harmonic phase (HARP) MRI. Magn Reson Med 42: 1048–1060, 1999.[CrossRef][Web of Science][Medline]
25. Power TP, Kramer CM, Shaffer AL, Theobald TM, Petruolo S, Reichek N, and Rogers WJ Jr. Breath-hold dobutamine magnetic resonance myocardial tagging: normal left ventricular response. Am J Cardiol 80: 1203–1207, 1997.[CrossRef][Web of Science][Medline]
26. Rademakers FE, Buchalter MB, Rogers WJ, Zerhouni EA, Weisfeldt ML, Weiss JL, and Shapiro EP. Dissociation between left ventricular untwisting and filling. Accentuation by catecholamines. Circulation 85: 1572–1581, 1992.[Abstract/Free Full Text]
27. Rademakers FE, Rogers WJ, Guier WH, Hutchins GM, Siu CO, Weisfeldt ML, Weiss JL, and Shapiro EP. Relation of regional cross-fiber shortening to wall thickening in the intact heart. Three-dimensional strain analysis by NMR tagging. Circulation 89: 1174–1182, 1994.[Abstract/Free Full Text]
28. Stuber M, Nagel E, Fischer SE, Spiegel MA, Scheidegger MB, and Boesiger P. Quantification of the local heart wall motion by magnetic resonance myocardial tagging. Comput Med Imaging Graph 22: 217–228, 1998.[CrossRef][Web of Science][Medline]
29. Stuber M, Scheidegger MB, Fischer SE, Nagel E, Steinemann F, Hess OM, and Boesiger P. Alterations in the local myocardial motion pattern in patients suffering from pressure overload due to aortic stenosis. Circulation 100: 361–368, 1999.[Abstract/Free Full Text]
30. Stuber M, Spiegel MA, Fischer SE, Scheidegger MB, Danias PG, Pedersen EM, and Boesiger P. Single breath-hold slice-following CSPAMM myocardial tagging. MAGMA 9: 85–91, 1999.[Medline]
31. Wahl A, Paetsch I, Gollesch A, Roethemeyer S, Foell D, Gebker R, Langreck H, Klein C, Fleck E, and Nagel E. Safety and feasibility of high-dose dobutamine-atropine stress cardiovascular magnetic resonance for diagnosis of myocardial ischemia: experience in 1,000 consecutive cases. Eur Heart J 25: 1–7, 2004.[Free Full Text]
32. Waters DD, Da Luz PD, and Wyatt HI. Early changes in regional and global left ventricular function induced by graded reductions in coronary perfusion. Am J Cardiol 39: 537, 1977.[CrossRef][Web of Science][Medline]
33. Zerhouni EA, Parish DM, Rogers WJ, Yang A, and Shapiro EP. Human heart: tagging with MR imaging–a method for noninvasive assessment of myocardial motion. Radiology 169: 59–63, 1988.[Abstract/Free Full Text]

This article has been cited by other articles:

				T. Lockie, E. Nagel, S. Redwood, and S. Plein Use of Cardiovascular Magnetic Resonance Imaging in Acute Coronary Syndromes Circulation, March 31, 2009; 119(12): 1671 - 1681. [Full Text] [PDF]

				G. Korosoglou, D. Lossnitzer, D. Schellberg, A. Lewien, A. Wochele, T. Schaeufele, M. Neizel, H. Steen, E. Giannitsis, H. A. Katus, et al. Strain-Encoded Cardiac MRI as an Adjunct for Dobutamine Stress Testing: Incremental Value to Conventional Wall Motion Analysis Circ Cardiovasc Imaging, March 1, 2009; 2(2): 132 - 140. [Abstract] [Full Text] [PDF]

				I. Paetsch, C. Jahnke, V. A. Ferrari, F. E. Rademakers, P. A. Pellikka, W. G. Hundley, D. Poldermans, J. J. Bax, K. Wegscheider, E. Fleck, et al. Determination of interobserver variability for identifying inducible left ventricular wall motion abnormalities during dobutamine stress magnetic resonance imaging Eur. Heart J., June 2, 2006; 27(12): 1459 - 1464. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) All Versions of this Article: 288/6/H2708    most recent 01017.2003v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (14) Citing Articles via Google Scholar Google Scholar Articles by Paetsch, I. Articles by Nagel, E. Search for Related Content PubMed PubMed Citation Articles by Paetsch, I. Articles by Nagel, E.